Mounjaro®
Starting from £179.99/mo
Start journey Learn moreDiarrhoea and vomiting are among the most commonly reported side effects of Wegovy (semaglutide), particularly in the first few weeks of treatment or after a dose increase. Most people find these symptoms are short-lived and manageable, but knowing what's normal, what helps, and when to seek medical attention makes a real difference. Wegovy is a prescription-only medicine, and your prescriber will weigh up your individual health picture before recommending it. If you're reading this mid-titration and feeling miserable, you're not alone — a significant proportion of people starting GLP-1 treatment go through a rough patch before things settle.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide, the active ingredient in Wegovy, works by mimicking a gut hormone called GLP-1. It slows how quickly food moves out of the stomach, reduces appetite, and acts on areas of the brain involved in hunger signalling. That slowing of gastric emptying is precisely what produces the gastrointestinal side effects many people experience. The stomach, in effect, takes longer to clear its contents, which can lead to nausea, vomiting, and looser stools as the gut adjusts to a new rhythm.
The NHS medicines page for semaglutide lists nausea, vomiting, diarrhoea, constipation, indigestion and burping as common side effects, all part of the same underlying mechanism. Symptoms are usually dose-dependent: they tend to peak in the days immediately after an injection, particularly following a dose step-up, and then soften as your body acclimates. For most people, they are manageable rather than severe. For some, they are significant enough to delay or pause titration, which is a clinical decision your prescriber can guide.
Knowing the cause doesn't make the nausea more pleasant, but it does explain why the experience is so consistent across people starting GLP-1 treatment. It's biology, not a sign that the medicine is wrong for you.
There is no single method that works for everyone, but several approaches are consistently described as helpful. Eating smaller portions more slowly, avoiding fatty or rich foods in the days after an injection, and not lying down immediately after a meal can all reduce the intensity of vomiting that some people experience on Wegovy. Staying well hydrated matters more than usual when diarrhoea is present; small, frequent sips are easier to tolerate than large quantities at once.
If vomiting is occurring regularly, maintaining adequate fluid and electrolyte intake becomes a priority. Plain water, diluted juice, or oral rehydration solutions are all reasonable options. Food choices that tend to sit more easily include plain rice, toast, or boiled potatoes; high-fat, spicy or very sweet foods often worsen GI symptoms during titration. For more detail on managing sickness specifically, our page on reducing vomiting on Wegovy covers additional strategies.
Timing matters too. Some people find symptoms are worse when they inject in the morning on an empty stomach; others prefer to inject in the evening so any peak discomfort passes during sleep. There is no universally right answer, your prescriber can help you find the pattern that suits your circumstances. Never adjust your dose or timing independently without clinical input.
Most vomiting and diarrhoea during Wegovy treatment does not require a trip to A&E. But there are specific circumstances where it does. Seek urgent medical attention if you experience any of the following.
First, if you are dealing with nausea and vomiting on Wegovy so frequently or severely that you cannot keep any fluids down for more than 24 hours, dehydration becomes a real risk, particularly for people with kidney conditions or those on other medications. Second, if you develop severe abdominal pain that reaches into your back, with or without vomiting, do not wait. This symptom pattern can indicate acute pancreatitis, which the MHRA flagged in a Drug Safety Update in January 2026 as an infrequent but serious risk associated with GLP-1 receptor agonists. Third, signs of significant dehydration (dizziness when standing, very dark urine, rapid heartbeat, confusion) need same-day assessment.
For broader information about the full range of side effects associated with this medicine, the Wegovy side effects guide on this site covers what to watch for across the treatment period. If you have a concern that falls between routine discomfort and emergency, our clinical team is reachable through aftercare support seven days a week.
You can also report any suspected side effect directly to the MHRA using the Yellow Card scheme. Patient reports genuinely contribute to the ongoing safety monitoring of medicines like Wegovy.
Gastrointestinal side effects are not a reason most people stop Wegovy treatment, but they can be if they are not well managed. The titration schedule (beginning at a low dose and increasing gradually over months) is specifically designed to reduce their impact. Starting at 0.25mg is not arbitrary; it gives the body time to adjust before reaching the doses associated with the most meaningful weight loss.
If you are weighing up whether Wegovy is suitable for you, or comparing it with other licensed options, the Wegovy overview and the weight-loss treatments pages set out the full picture. Wegovy is a prescription-only medicine, and any decision to start, pause or change treatment sits with a clinician who knows your health history. At nume, that review is carried out by a GPhC-registered prescriber (a real clinician reading your individual assessment) before any prescription is issued. Our prescribers routinely discuss the likelihood and management of side effects like diarrhea on Wegovy and vomiting as part of the consultation, so you go in with a clear idea of what to expect. If you'd like that conversation, you can start your free consultation today.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.